Atlantic Edge Private Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
SI
CPC
KAS
GGI
FWCM
QCM
DADC
MIM
Atlantic Edge Private Wealth Management's NVS Position: Q2 2026 in Review
Atlantic Edge Private Wealth Management increased its Novartis (NVS) stake by 1.8% in Q2 2026, buying an estimated $6K and bringing the position to 2,270 shares worth $356K. The position accounts for 0.07% of the portfolio, ranked #114.
Atlantic Edge Private Wealth Management first reported a position in NVS in Q4 2023 and has held it in 11 quarters since. 612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Atlantic Edge Private Wealth Management held 2,270 shares of Novartis worth $356K as of Q2 2026.
- Atlantic Edge Private Wealth Management bought 40 Novartis shares in Q2 2026, an estimated $6K.
- Novartis made up 0.07% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #114 holding.
- Atlantic Edge Private Wealth Management first reported a position in Novartis in Q4 2023 and has held it in 11 quarters since.
- 612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.